ORGO
Organogenesis Holdings Inc
1.40$
-2.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 23.8% | 27.9% | 26.1% | 22.4% | 23.3% | 24.5% | 27.4% | 27.4% | 24.1% | 22.2% | 102.5% | 54.1% | 32.4% | |
| 76.2% | 72.1% | 73.9% | 77.6% | 76.7% | 75.5% | 72.6% | 72.6% | 75.9% | 77.8% | -2.5% | 45.9% | 67.6% | |
| 9.6% | 11.8% | 11.6% | 12.0% | 9.0% | 9.1% | 12.3% | 10.3% | 8.8% | 4.6% | 40.7% | 41.8% | 12.5% | |
| 59.2% | 48.1% | 65.8% | 58.8% | 62.3% | 55.3% | 83.6% | 73.2% | 53.0% | 44.5% | 175.1% | 123.3% | 65.5% | |
| 68.8% | 73.4% | 77.4% | 88.2% | 71.3% | 67.4% | 95.9% | 83.3% | 61.5% | 48.8% | 172.2% | 162.4% | 74.0% | |
| 7.4% | -1.3% | -3.5% | -10.7% | 5.4% | 8.1% | -23.3% | -10.7% | 14.4% | 29.0% | -174.7% | -116.5% | -6.4% | |
| 0.4% | 0.5% | 0.5% | 0.5% | 0.4% | 0.0% | 1.1% | 0.7% | 0.3% | 0.1% | – | – | – | |
| 7.0% | -1.8% | -3.9% | -11.2% | 5.1% | 8.1% | -29.7% | -11.7% | 14.1% | 28.2% | -183.9% | -116.3% | -7.6% | |
| 4.1% | -1.2% | -2.0% | 1.9% | -5.7% | 2.0% | -8.0% | -2.4% | -0.3% | 8.8% | -33.1% | 103.7% | 11.5% | |
| 2.9% | -0.6% | -1.9% | -13.1% | 10.7% | 6.1% | -21.7% | -9.3% | 14.3% | 19.4% | -150.9% | -227.0% | -19.8% | |
| 12.8% | 11.0% | 0.1% | -7.5% | 9.3% | 11.6% | -22.5% | -5.1% | 18.7% | 31.3% | -150.7% | -107.9% | -1.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.